HiberCell Competitors and Similar CompaniesClear all
HiberCell's competitors and similar companies include Eisbach Bio and PEP-Therapy.
 HiberCell HiberCell is a company that focuses on therapeutically modulating the biology and mechanisms of tumor dormancy. |  Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. | |
Founding Date | Founding Date 2019 | Founding Date 2019 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations New York, US HQ Roseville, US | Locations Planegg, DE HQ | Locations Paris, FR HQ Évry, FR |
Employees | Employees 264% decrease | Employees 118% decrease | Employees 14 |
Funding | |||
Latest funding round | Latest funding round $ 67.4m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 3m (almost 5 years ago) |
Total funding raised | Total funding raised $ 128.2m | Total funding raised N/A | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Eisbach Bio
HQ
Planegg, DE
Employees
11↓ 8% decrease
Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes.
View companyPEP-Therapy
HQ
Paris, FR
Employees
14
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View company